A detailed history of Goodwin Daniel L transactions in Eli Lilly & CO stock. As of the latest transaction made, Goodwin Daniel L holds 700 shares of LLY stock, worth $547,386. This represents 0.18% of its overall portfolio holdings.

Number of Shares
700
Previous 700 -0.0%
Holding current value
$547,386
Previous $328,000 14.33%
% of portfolio
0.18%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $35,074 - $46,898
-100 Reduced 12.5%
700 $328,000
Q1 2023

Apr 20, 2023

BUY
$310.63 - $364.82 $31,063 - $36,482
100 Added 14.29%
800 $274,000
Q1 2022

Apr 21, 2022

BUY
$234.69 - $291.66 $164,283 - $204,162
700 New
700 $200,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Goodwin Daniel L Portfolio

Follow Goodwin Daniel L and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goodwin Daniel L, based on Form 13F filings with the SEC.

News

Stay updated on Goodwin Daniel L with notifications on news.